These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34966136)

  • 1. Treatment of Cutaneous Leishmaniasis in a Nonendemic Country: A Case Series of Children in Australia.
    Hill N; Irwin A; Graham N; Leung C; Francis JR; Wall N; Nourse C
    Pediatr Infect Dis J; 2022 Apr; 41(4):e177-e181. PubMed ID: 34966136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.
    Chacko A; Joseph M; Feltis T; Morris SK
    Am J Trop Med Hyg; 2016 Oct; 95(4):793-794. PubMed ID: 27549634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole for the treatment of cutaneous leishmaniasis.
    Zvulunov A; Klaus S; Vardy D
    N Engl J Med; 2002 Aug; 347(5):370-1; author reply 370-1. PubMed ID: 12151480
    [No Abstract]   [Full Text] [Related]  

  • 4. Unsuccessful treatment of cutaneous leishmaniasis by Leishmania infantum with topical paromomycin.
    Veraldi S; Benzecry Mancin V; Faraci AG; Nazzaro G
    Int J Dermatol; 2020 Jul; 59(7):e251-e252. PubMed ID: 31975375
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.
    Mussi SV; Fernandes AP; Ferreira LA
    Parasitol Res; 2007 May; 100(6):1221-6. PubMed ID: 17206508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical status of agents being developed for leishmaniasis.
    Berman J
    Expert Opin Investig Drugs; 2005 Nov; 14(11):1337-46. PubMed ID: 16255674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occlusive paromomycin for cutaneous leishmaniasis.
    Bell SA; Schaller M; Röcken M
    Lancet; 1997 Jan; 349(9044):29. PubMed ID: 8988124
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
    Krause G; Kroeger A
    Clin Infect Dis; 1999 Aug; 29(2):466-7. PubMed ID: 10476776
    [No Abstract]   [Full Text] [Related]  

  • 9. Occlusive paromomycin for cutaneous leishmaniasis.
    Bryceson AD
    Lancet; 1997 May; 349(9063):1477. PubMed ID: 9164342
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z; Nakhli A; Rassaii S
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous Leishmaniasis in an American Adolescent Returning From Israel.
    Ganjaei KG; Lawton K; Gaur S
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):e178-e181. PubMed ID: 29878238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of pediatric cases of cutaneous leishmaniasis with oral fluconazole.
    Mitra D; Bhatnagar A; Patil C; Kothari R
    Int J Dermatol; 2023 Apr; 62(4):e251-e252. PubMed ID: 36371688
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
    Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous leishmaniasis].
    Enk CD; Gardlo K; Hochberg M; Ingber A; Ruzicka T
    Hautarzt; 2003 Jun; 54(6):506-12. PubMed ID: 12759734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous leishmaniasis treatment.
    Minodier P; Parola P
    Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous leishmaniasis mimicking granulomatous cheilitis and treated successfully with oral fluconazole in a boy.
    Serarslan G; Aksakal M
    Ann Parasitol; 2015; 61(3):197-9. PubMed ID: 26568994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous leishmaniasis in two siblings.
    Houssami L; Haddad F; El Teraifi H; Berger TG
    Eur J Dermatol; 2006; 16(3):310-1. PubMed ID: 16709502
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
    Soto J; Soto P; Ajata A; Luque C; Tintaya C; Paz D; Rivero D; Berman J
    Clin Infect Dis; 2019 Feb; 68(5):844-849. PubMed ID: 30260376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of cutaneous leishmaniasis in adults and children].
    Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
    Med Trop (Mars); 2005 Nov; 65(5):487-95. PubMed ID: 16465821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M; Schuster BG; Ellis WY; Berman JD
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.